Hugh McMillan
Professor, Department of Pediatrics, University of Ottawa
Pediatric Neurologist and Neuromuscular specialist at the Children’s Hospital of Eastern Ontario
Email HughDr. McMillan is a Pediatric Neurologist with specialization in Clinical Neurophysiology and Neuromuscular medicine at the Children’s Hospital of Eastern Ontario. He is a Professor in the Department of Pediatrics, Faculty of Medicine at the University of Ottawa. He holds a Clinical Research Chair (Level 2) at the University of Ottawa and is a Clinical Investigator at the CHEO Research Institute
He has been an author of over 125 publications in peer-review journals and was a co-editor of a Pediatric Electromyography textbook. He is also a leader in clinical and translational research in pediatric neurology & neuromuscular medicine.
Dr. McMillan completed a Neuromuscular and Neurophysiology Fellowship at Boston Children’s Hospital, Harvard University and the Lahey Clinic, Tufts University; a Pediatric Neurology Residency at the Children’s Hospital of Eastern Ontario, University of Ottawa and a Pediatric Residency at McMaster Children’s Hospital, McMaster University.
Read more about Hugh
Recent publications
Freeman, E, Langlois, S, Leyba, MF, Ammar, T, Léger, Z, McMillan, HJ et al.. Pannexin 1 dysregulation in Duchenne muscular dystrophy and its exacerbation of dystrophic features in mdx mice. Skelet Muscle. 2024.14 (1)8 PMID:38671506
Dang, UJ, Damsker, JM, Guglieri, M, Clemens, PR, Perlman, SJ, Smith, EC et al.. Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy: A Randomized Controlled Trial. Neurology. 2024.102 (5)e208112 PMID:38335499
Muntoni, F, Byrne, BJ, McMillan, HJ, Ryan, MM, Wong, BL, Dukart, J et al.. The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy. Neurol Ther. 2024.13 (1)183-219 PMID:38190001
Longmuir, PE, Chubbs Payne, A, Beshara, N, Brandão, LR, Wright, FV, Pohl, D et al.. Quick, Effective Screening Tasks Identify Children With Medical Conditions or Disabilities Needing Physical Literacy Support. Pediatr Exerc Sci. 2024. 1-11 PMID:38171358
Baranello, G, Neurodevelopment in SMA Working Group. The emerging spectrum of neurodevelopmental comorbidities in early-onset Spinal Muscular Atrophy. Eur J Paediatr Neurol. 2024.48 67-68 PMID:38043384
McMillan, HJ, Lochmüller, H. Sustained clinical benefit following systemic gene replacement therapy in Duchenne muscular dystrophy. Muscle Nerve. 2024.69 (1)4-6 PMID:37969074
Saettini, F, Guerra, F, Fazio, G, Bugarin, C, McMillan, HJ, Ohtake, A et al.. Correction to: Antibody Deficiency in Patients with Biallelic KARS1 Mutations. J Clin Immunol. 2023.43 (8)2126 PMID:37921915
Nigro, E, Grunebaum, E, Kamath, B, Licht, C, Malcolmson, C, Jeewa, A et al.. Case report: A case of spinal muscular atrophy in a preterm infant: risks and benefits of treatment. Front Neurol. 2023.14 1230889 PMID:37780708
Saettini, F, Guerra, F, Fazio, G, Bugarin, C, McMillan, HJ, Ohtake, A et al.. Antibody Deficiency in Patients with Biallelic KARS1 Mutations. J Clin Immunol. 2023.43 (8)2115-2125 PMID:37770806
Buttle, SG, McMillan, HJ, Davila, J, Bokhaut, J, Kovesi, T, Katz, SL et al.. Respiratory failure in a patient with VACTERL association and concomitant spinal muscular atrophy. Pediatr Pulmonol. 2023.58 (11)3314-3319 PMID:37750602
See more on PubMed